May 20 - 23, 2012    Las Vegas NV , Vereinigte Staaten
Oligonucleotide and Peptide Manufacturing Technology and Product Development

Case Studies on CMC Challenges, Early Drug Product Development and Delivery Alternatives

Plan for the future as you enjoy a dynamic keynote session including:

* A bright forecast for oligonucleotide therapeutic progress despite recent pharma changes
* An analysis of RNAi activities in China which will form the new "RNAi Valley"
* Strategies to leverage current technology platforms to target best-in-class therapeutics based on peptide hormones
* A report on re-programming the genetic code for discovery of peptide therapeutics.

Ort

Location: Mandalay Bay Resort
Kontaktieren Las Vegas , USA